CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 535996-536082 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T86737","span":{"begin":0,"end":86},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Our results support further evaluation of atorvastatin and rosuvastatin in MS therapy."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T257","span":{"begin":0,"end":86},"obj":"Sentence"}],"text":"Our results support further evaluation of atorvastatin and rosuvastatin in MS therapy."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2283","span":{"begin":75,"end":77},"obj":"Body_part"}],"attributes":[{"id":"A2283","pred":"uberon_id","subj":"T2283","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"Our results support further evaluation of atorvastatin and rosuvastatin in MS therapy."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3361","span":{"begin":75,"end":77},"obj":"Disease"},{"id":"T12498","span":{"begin":75,"end":77},"obj":"Disease"}],"attributes":[{"id":"A3361","pred":"mondo_id","subj":"T3361","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A14915","pred":"mondo_id","subj":"T12498","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"Our results support further evaluation of atorvastatin and rosuvastatin in MS therapy."}